Experts to get cracking, now
The Free Press Journal|December 27, 2021
To decide which vaccine is to be given to kids; which vaccine will be the booster dose; and what will be the gap between the last dose and the 'precautionary shot for elderly

The country's two top panels on Covid vaccination will get cracking in the coming week. They will be making key recommendations which will help the government firm up crucial decisions -- which vaccine is to be administered to children above 15; which vaccine will be the booster dose; and what will be the gap between the last dose and the 'precautionary' dose for the elderly.

For children, the toss-up is essentially between Covaxin and Zydus Cadila, though two more vaccinations are lined up. Till now, the understanding is that both will be used, a media report said. The data on trials in the 12+ age group and the 15 to 18 eligible criteria is, however, still not in public domain and has to be reviewed by experts.

Continue reading your story on the app

Continue reading your story in the newspaper

MORE STORIES FROM THE FREE PRESS JOURNALView All

I will definitely be around IPL next year, says AB de Villiers

De Villiers had been a big part of RCB family before he retired from all forms of cricket last year.

1 min read
The Free Press Journal
May 25, 2022

SRK charms fans with his signature pose

Bollywood superstar Shah Rukh Khan never misses an opportunity to charm his fans and a latest video is a proof of the same.

1 min read
The Free Press Journal
May 25, 2022

Willing to meet Putin to end war, says Zelenskyy

Ukrainian President Volodymyr Zelenskyy said on Monday that President Vladimir Putin was the only Russian official he was willing to meet with to discuss how to end the war, as per reports by the Reuters.

1 min read
The Free Press Journal
May 25, 2022

LIC to declare Jan-Mar, FY22 results on May 30

It is informed that a meeting of the Board of Directors of the Corporation is scheduled to be held on May 30, 2022, LIC said in a regulatory filing on Tuesday.

1 min read
The Free Press Journal
May 25, 2022

Further FX reserve slump may cause alarm: IFA Global

India's foreign exchange reserves stood at $593.28 bln as on May 13, down around $49 bln from the peak in October.

1 min read
The Free Press Journal
May 25, 2022

May strike after meeting with Centre: Petrol dealers

Demands include reimbursement of money lost due to reduced taxes and an increase in commission

2 mins read
The Free Press Journal
May 25, 2022

SRA declaration waived, schemes on fast-track

Slumdwellers and developers are expected to save at least three months of legal and procedural formalities; will stop the delay in sanctioning slum rehab projects, says state housing minister

2 mins read
The Free Press Journal
May 25, 2022

Addressing Bhiwandi's 'elephant' in the room

The administration has taken a fortnightly drive in Bhiwandi, a hotbed of elephantiasis cases

1 min read
The Free Press Journal
May 25, 2022

China, Russia N-bombers cock a snook at summit

Chinese and Russian strategic bombers flew over the Sea of Japan as US President Joe Biden and PM Modi hobnobbed at a Quad summit in Tokyo.

1 min read
The Free Press Journal
May 25, 2022

MUMBAI HAADSON KA SHEHER

However, the death of over 5,000 people in road mishaps in just four months does not seem to be unduly worrying to traffic authorities.

2 mins read
The Free Press Journal
May 25, 2022
RELATED STORIES

बच्चों के लिए कोरोनारोधी दो टीकों को मंजूरी

औषधि महानियंत्रक का फैसला

1 min read
Jansatta
April 27, 2022

6 साल के बच्चों के टीके को आपात मंजूरी

जायकोव-डी को 12 साल से अधिक उम्र के बच्चों को लगाने की मंजूरी मिली

1 min read
Business Standard - Hindi
April 27, 2022

Covaxin cleared for 6-12 age group, Corbevax for 5 to 12-year-olds

70% people who took booster dose didn't get Covid during 3rd wave in India, says study

2 mins read
Millennium Post Delhi
April 27, 2022

Expert panel backs use of Corbevax in 5+ age group

An expert committee advising India's drugs regulator has recommended Biological E-made coronavirus vaccine Corbevax be approved for emergency use in children aged five and above, officials said on Thursday, making it the second shot to be backed for use in the under-12 age group although a final decision will need to be taken by the regulator and then the government.

2 mins read
Hindustan Times
April 22, 2022

A first in 716 days: Daily Covid cases below 1,000

Consistently Declining For Over 10 Weeks

1 min read
The Times of India Mumbai
April 05, 2022

Bharat Biotech's Booster Shots

Ella siblings Raches and Jalachari, who played a key role in development of Covaxin, now plan to take Bharat Biotech into newage products and therapies to beat chronic diseases such as cancer.

6 mins read
Fortune India
April 2022

Bharat Biotech: Temporarily slowing down production of Covaxin

Bharat Biotech on Friday said it is temporarily slowing down production of its COVID-19 vaccine Covaxin across its manufacturing units for facility optimisation as it has already completed its supply obligations to procurement agencies and foresees decrease in demand. 

2 mins read
Millennium Post Delhi
April 02, 2022

Expert panel recommends granting nod to Serum's Covovax for 12-17 yr-olds

AN EXPERT PANEL of the country's central drug authority has recommended granting emergency use authorisation (EUA) to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday.

1 min read
Financial Express Mumbai
March 05, 2022

Corbevax gets nod for 12-18-yr group

BIOLOGICAL E, A Hyderabad-based vaccine manufacturer, on Monday received emergency use authorisation (EUA) from India's drug regulator for their Covid-19 vaccine for the 12 to 18-year age group.

1 min read
Financial Express Mumbai
February 22, 2022

Dr Reddy's all set to launch Sputnik Light as booster dose

DR REDDY'S LABORATORIES said it was looking at introducing the Sputnik Light Covid-19 vaccine as a booster dose in the country.

1 min read
Financial Express Mumbai
February 08, 2022